Cielo Biotech Private Limited

Cielo Biotech Private Limited - life sciences in Chennai, Tamil Nadu, India. FY 2026 financials and compliance.
CIN U51909TN2014PTC098130 Incorporated 20 November 2014 ROC Chennai HQ Chennai, Tamil Nadu, India
Active Private Limited Company life sciences
Data last updated
Revenue · FY 2022
₹7.42 Cr
▲ 4.00% YoY
EBITDA · FY 2022
*****
▼ 125.00% YoY
Net profit · FY 2022
*****
▼ 179.00% YoY
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
None
Secured borrowings
Company age
12 yrs
Est. 2014
Last financials
Mar 2022
Balance sheet date

About Cielo Biotech Private Limited

Data last updated: 07 March 2026

Cielo Biotech Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It specialises in biotechnology, a part of the broader life sciences sector. Incorporated on 20 November 2014, the company has been in operation for over 12 years.

Registered with ROC Chennai under CIN U51909TN2014PTC098130.

Capital: an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Razia Gajendrababu and Fred Jonathan Ananth.

Last AGM: 30 September 2022. Financial statements filed for year ended 31 March 2022. Office: Chennai, Tamil Nadu.

As per the financials filed for FY 2022, the company reported a revenue of ₹7.42 Cr, a growth of 4% compared to the previous year.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website cielobiotech.com.

Company Details of Cielo Biotech Private Limited
CIN U51909TN2014PTC098130
Registration Number 098130
Incorporation Date 20 November 2014
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2022
Date of Balance Sheet 31 March 2022
Compliance Status Active Compliant
Key People
Razia Gajendrababu Director Fred Jonathan Ananth Director Vinay Devabhakthuni Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    **************
  • Website
    cielobiotech.com
  • Social Media
    **************
  • Registered Address
    Door No. 30 Second Floor Psg Tam Flats North Mada Street Srinagar Colony Said, Apet, Chennai, Tamil Nadu, India – 600015
  • Industry
    Life Sciences, Biotechnology
Company report
Cielo Biotech Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Cielo Biotech Private Limited report

Financials, compliance, directors, charges, ownership and filings for Cielo Biotech Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Business Activity of Cielo Biotech Private Limited

Cielo Biotech Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including metal and metal products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C7 Metal and metal products *********

Auditor Details of Cielo Biotech Private Limited

Auditor information for Cielo Biotech Private Limited provides details about the firm responsible for auditing the company's financial statements and ensuring compliance with regulatory requirements.

Board of Directors of Cielo Biotech Private Limited

Cielo Biotech Private Limited is governed by 3 directors who oversee the company's operations and strategic decisions.

Current Directors
Name Designation Appointment Date Tenure Status
Razia Gajendrababu Director 01 Mar 2019 7 Years 4 Months Current
Fred Jonathan Ananth Director 20 Nov 2014 11 Years 7 Months Current
Vinay Devabhakthuni
Also directs: Quatrade Llp, Ramaratnam Trading (Opc) Private Limited
Director 20 Nov 2014 11 Years 7 Months Current
View all directors

Financials of Cielo Biotech Private Limited FY 2022 filings available

Cielo Biotech Private Limited reported revenue of ₹7.42 Cr (up 4% YoY) for FY 2022. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue
₹7.42 Cr ▲ 4%
Profit
***** ▼ -179%
EBITDA
***** ▼ -125%
Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Shareholding Pattern of Cielo Biotech Private Limited

As of FY 2020, Cielo Biotech Private Limited's shareholding pattern shows 100.00% by promoters. The promoters hold a majority stake, indicating strong promoter control.

2025
YEAR
38.19% Promoters
25.22% DII (Domestic Institutional)
10.28% FII (Foreign Institutional)
25.89% Public
2.42% Others
Shareholding Trend
Year 2025
Promoters 33.19%
DII 23.22%
FII 18.28%
Public 22.89%
Others 2.42%

Charges & Borrowings Cielo Biotech Private Limited

Cielo Biotech Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Cielo Biotech Private Limited

View historical data on people associated with Cielo Biotech Private Limited, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Cielo Biotech Private Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Cielo Biotech Private Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Cielo Biotech Private Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Cielo Biotech Private Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Cielo Biotech Private Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Cielo Biotech Private Limited

MSME Payment Delays by Cielo Biotech Private Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Cielo Biotech Private Limited

Subsidiaries & Group Companies of Cielo Biotech Private Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Cielo Biotech Private Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Cielo Biotech Private Limited

MCA Filings & Documents of Cielo Biotech Private Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Cielo Biotech Private Limited

Activity
30 Sep 2022
Cielo Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
Activity
31 Mar 2022
Cielo Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Chennai.
Directors
01 Mar 2019
Razia Gajendrababu was appointed as a Director on 01 Mar 2019 & has been associated with this company since 7 years 4 months.
Directors
20 Nov 2014
Fred Jonathan Ananth was appointed as a Director on 20 Nov 2014 & has been associated with this company since 11 years 7 months.
Directors
20 Nov 2014
Vinay Devabhakthuni was appointed as a Director on 20 Nov 2014 & has been associated with this company since 11 years 7 months.
Activity
20 Nov 2014
Cielo Biotech Private Limited was registered on 20 Nov 2014 with Roc Chennai & aged 11 years 7 months as per MCA records.

Frequently Asked Questions about Cielo Biotech Private Limited

Cielo Biotech Private Limited is an active private limited company in the life sciences sector based in Chennai, Tamil Nadu, India. It was incorporated on 20 November 2014 (12+ years old) and is registered under CIN U51909TN2014PTC098130.

Cielo Biotech Private Limited reported revenue of ₹7.42 Cr for FY 2022 (up 4.00% YoY).

The current directors of Cielo Biotech Private Limited are:

The primary industry of Cielo Biotech Private Limited is life sciences. The company specifically operates in biotechnology. The company is currently active in this sector.

Cielo Biotech Private Limited can be reached at the registered office: Door No. 30 Second Floor Psg Tam Flats North Mada Street Srinagar Colony Said, Apet, Chennai, Tamil Nadu, India – 600015, or through the website cielobiotech.com.

The authorised capital is ₹5 Lakh, and the paid-up capital is ₹1 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available